Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,318.00
Bid: 1,315.00
Ask: 1,319.00
Change: 43.00 (3.37%)
Spread: 4.00 (0.304%)
Open: 1,289.00
High: 1,318.00
Low: 1,267.00
Prev. Close: 1,275.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE 100 tops 8,000; Centrica is star performer

Thu, 16th Feb 2023 08:49

(Alliance News) - Stock prices in London opened higher on Thursday, with London's blue-chip index pushing past the 8,000 mark once again, a day after it first broke the barrier.

The FTSE 100 index was up 26.04 points, 0.3%, at 8,023.87. It hit a new record high of 8,046.00 points earlier in the morning.

The FTSE 250 was up 50.25 points, 0.3%, at 20,222.84, and the AIM All-Share was up 0.62 of a point, or 0.1%, at 870.15.

The Cboe UK 100 was up 0.3% at 803.05, the Cboe UK 250 flat at 17,564.68, and the Cboe Small Companies up 0.3% at 14,059.05.

The pound was stronger on Thursday morning, though still bruised by UK inflation data on Wednesday that offered the Bank of England room to slow or stop UK interest rate hikes.

Inflation in the UK slowed by slightly more than forecast in January, though remained in double digits, figures from the Office for National Statistics showed. On an annual basis, the consumer price index eased to 10.1% in January from 10.5% in December. Consensus had expected inflation to cool to 10.3%, according to FXStreet.

The pound was quoted at USD1.2053 at early on Thursday in London, higher compared to USD1.2007 at the equities close on Wednesday.

Centrica was the best performing stock in the FTSE 100, up 4.0%.

The British Gas-owner swung to a statutory loss on re-measurement and higher operating costs, while adjusted profit tripled as revenue surged 84%.

The Windsor-based firm announced a pretax loss of GBP240 million in 2022, compared to a profit of GBP954 million in 2021. Revenue jumped 84% to GBP33.64 billion from GBP18.30 billion.

The swing to a loss was on re-measurements after taxation, Centrica said, largely reflecting the revaluation of UK energy supply hedging positions due to wholesale gas and power price falls towards the end of the year. The cost for re-measurement and settlement of derivative energy contracts ballooned to GBP8.48 billion in 2022 from GBP434 million in 2021.

However, adjusted operating profit tripled to GBP3.31 billion from GBP948 million on the revenue rise.

Centrica said it intends to extend its existing GBP250 million buyback programme, announced in November, by an additional GBP300 million. This would result in Centrica buying back 10% of its share capital, the power utility said. The company also proposed a full-year dividend of 2.0 pence, compared to none in 2021.

Relx up 3.0% after it posted double-digit rises in full year profit and revenue. The professional information publisher said it plans to spend GBP800 million on share buybacks in 2023.

In 2022, pretax profit rose 18% to GBP2.11 billion from GBP1.80 billion in 2021, while revenue climbed 18% to GBP8.55 billion from GBP7.24 billion.

Looking ahead, Relx said momentum remains strong across the group. It expects underlying growth rates in revenue and adjusted operating profit to remain above historical trends.

Standard Chartered shares rose 3.1%. The bank reported pretax profit of USD4.29 billion in 2022, up from USD3.35 billion in 2021, as interest income jumped by nearly 50% to USD15.25 billion from USD10.25 billion.

The Asia-focused lender said it was optimistic about the reopening of China and for economic growth in Asia in the year ahead.

In the FTSE 250, Indivior plunged 11%. The pharmaceutical firm swung to a pretax loss of USD95 million in 2022 from a profit of USD190 million the previous year.

Indivior explained that it booked a USD290 million exceptional provision in the year as it navigates initial mediation sessions in late January regarding legacy civil multi-district antitrust litigation.

"Because these matters are in various stages, Indivior cannot predict with any certainty how these matters will ultimately be resolved, or the costs, or timing of such resolution. In particular, any final aggregate costs of these matters, whether resolved by settlement or trial, may be materially different from this provision," the company added.

Elsewhere in London, Coca-Cola Europacific Partners shares slipped 0.2%.

The soft-drinks bottling company reported jumps in pretax profit and revenue in 2022 as it declared a record full-year interim dividend of EUR1.68, up 20% against the prior year.

In 2022, pretax profit totalled EUR1.96 billion, up from EUR1.38 billion the year prior. Revenue climbed to EUR17.32 billion from EUR13.76 billion year-on-year.

Looking forward, Coca-Cola EP said it expects comparable revenue growth of between 6% and 8% in 2023.

In European equities on Thursday, the CAC 40 index in Paris was up 1.0%, while the DAX 40 in Frankfurt was up 0.7%.

European Central Bank President Christine Lagarde reiterated Wednesday that the ECB plans to raise its interest rates by half a percentage point.

Data released on Monday showed the 20-nation currency bloc dodged a recession at the end of last year by posting weak-but-positive growth of 0.1%, while inflation has been easing – even if it remains at a high 8.5%.

"In view of the underlying inflation pressures we intend to raise interest rates by another 50 basis points at our next meeting in March," Lagarde told lawmakers at the European Parliament.

The euro stood at USD1.0713 early Thursday, higher against USD1.0669 at the London equities close on Wednesday. Against the yen, the dollar was trading at JPY133.78, lower compared to JPY134.32.

In Tokyo on Thursday, the Nikkei 225 index closed up 0.7%. In China, the Shanghai Composite closed down 1.0%, while the Hang Seng index in Hong Kong closed up 0.8%. The S&P/ASX 200 in Sydney closed up 0.8%.

New York ended higher on Wednesday, with the Dow Jones Industrial Average ending up 0.1%, the S&P 500 up 0.3%, and the Nasdaq Composite up 0.9%.

Brent oil was quoted at USD85.64 a barrel at early in London on Thursday, up from USD84.07 late Wednesday. Gold was quoted at USD1,840.05 an ounce, sharply higher against USD1,832.19.

The International Energy Agency has sharply raised its forecast for global crude oil demand because of the prospect of stronger economic growth in China.

For the whole year, the IEA expects an increase of 2 million barrels per day to an average of 101.9 million barrels per day.

Still to come on Thursday's economic calendar, the US will publish its weekly unemployment claims report at 1330 GMT alongside the producer price index.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
16 Feb 2022 09:16

TOP NEWS: Indivior swings to profit in 2021; mulling US listing

(Alliance News) - Indivior PLC shares jumped on Wednesday after it reported a swing to profit in 2021 and annual revenue moved closer to its eventual target of USD1 billion.

Read more
16 Feb 2022 09:00

LONDON MARKET OPEN: Geopolitical tensions calm but inflation in focus

(Alliance News) - London's FTSE 100 stock index edged cautiously higher in early dealings on Wednesday, with a seeming de-escalation by Russia of its threat to Ukraine lifting the mood, though traders were wary about a backdrop of inflationary pressures in both the UK and US.

Read more
16 Feb 2022 07:49

LONDON MARKET PRE-OPEN: Franchise Brands buys fellow AIM firm Filta

(Alliance News) - Stock prices in London are seen opening slightly higher on Wednesday, adding to strong gains on Tuesday, as tensions on the Russia-Ukraine border appear to have eased.

Read more
16 Feb 2022 07:05

Indivior considers US listing after returning to profit

(Sharecast News) - Indivior said it was considering a US listing for its shares as the drugs company swung to an annual profit and predicted strong growth for its Sublocade opioid.

Read more
9 Feb 2022 16:02

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
28 Jan 2022 16:22

UPDATE: Indivior notes robust results for treatment in fentanyl trial

UPDATE: Indivior notes robust results for treatment in fentanyl trial

Read more
28 Jan 2022 14:53

CORRECT: Indivior notes results for painkiller in fentanyl trial

CORRECT: Indivior notes results for painkiller in fentanyl trial

Read more
28 Jan 2022 09:02

Indivior's painkiller demonstrates positive interaction with fentanyl

Indivior's painkiller demonstrates positive interaction with fentanyl

Read more
28 Jan 2022 07:55

Indivior welcomes results from buprenorphine-fentanyl interaction study

(Sharecast News) - Pharmaceutical company Indivior hailed the results of a study aimed at assessing the ability of its buprenorphine asset to reduce respiratory depression and apnea associated with the synthetic opioid fentanyl.

Read more
19 Nov 2021 14:56

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

Read more
10 Nov 2021 12:28

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

Read more
10 Nov 2021 10:12

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

Read more
10 Nov 2021 08:07

Indivior slumps as Scopia Capital sells 20m shares

(Sharecast News) - Indivior was under the cosh on Wednesday after US alternative asset management firm Scopia Capital sold 20m shares in the opioid addiction treatment maker in a placing.

Read more
1 Nov 2021 09:38

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

Read more
28 Oct 2021 13:23

Indivior lifts 2021 revenue guidance amid strong Sublocade sales

Indivior lifts 2021 revenue guidance amid strong Sublocade sales

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.